News and Events
The NICM and its achievements were spoken of highly by the House of Representatives and the Members of Parliament from Macarthur, Throsby, Bennelong, Kingsford Smith, and Lindsay.
NICM's early-career researchers, Genevieve Steiner and Dr Jennifer Hunter have been selected to present their research at the FameLab
state finals, held on the 24 March at Sydney's Powerhouse Museum.
In March, the Weekend Post, CairnsEye reporter, Claudia Liebenberg wrote a feature article on complementary medicine and its place in modern healthcare titled Many Roads to Health.
SBS World News recently aired a segment about the $1.3 million research deal between Sydney University and Blackmores.
In February we saw the NICM's Adjunct Associate Professor, Vicki Kotsirilos, be the voice of reason in a story covered by Fairfax's Sydney Morning Herald regarding the American paper released which stated that herbal supplements didn't always contain the ingredients on the label.
August 2014 Media Release: If you are a parent/carer of a child with Autism Spectrum Disorder, who has used or is thinking of using complementary therapies and medicines (CM)
Media Release: The debate around industry funding of a new research centre, to be established at La Trobe University earlier this year, provided Professor Alan Bensoussan with an opportunity to respond to emerging challenges to evidence-based CM research.
March 2014Media Release: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
12 March 2014Media Release: NICM is undertaking clinical research into the use of a standardised Chinese herbal medicine formula to treat vascular dementia. A Multicentre, Randomised, Double Blind, Placebo Controlled Trial to Evaluate the Effectiveness and Safety of Sailuotong, a Standardised Chinese Herbal Medicine Formula in Patients with Vascular Dementia and Alzheimer's Disease with Cerebrovascular Disease.
Media Release: Professor Kelvin Chan and Dr Valentina Naumovski from the National Institute of Complementary Medicine along with Dr Srinivas Nammi from the School of Science and Health are investigating how a traditional Chinese medicine, extracted from a mushroom, interacts with two common cancer drugs. The project, which is supported by UWS and PuraPharm Pty., Ltd., Australia, is part of a wider study to determine if the mushroom extract could be used as an adjunct therapy for cancer.
